Nateglinide tablets are usually taken by adults at 60-120 mg three times a day, within 1-15 minutes before meals, and then the dosage is adjusted according to the results of the HbA1c test, with the maximum recommended single dose not exceeding 180 mg. Nateglinide Tablets is an oral hypoglycemic drug, belongs to non-sulfonylurea agonists, can stimulate the pancreatic β-cells to secrete insulin to reduce blood glucose, mainly used for patients with type 2 diabetes who cannot effectively control high blood glucose by diet and exercise, and can be used in combination with metformin. Some adverse reactions such as weight gain, hypoglycemia, etc. may occur when taking Nateglinide Tablets. It is forbidden to use it for people who are allergic to the drug, pregnant and lactating women, people with type 1 diabetes, diabetic ketoacidosis. Nateglinide tablets need to be used under the guidance of a doctor, follow the doctor’s instructions, reasonable use of medication.